Jennifer Friel Goldstein
Silicon Valley Bank
Managing Partner, Life Sciences & Healthcare, SVB Capital
Jennifer Friel Goldstein is the Managing Partner for Life Science & Healthcare at SVB Capital and a founding member of Venture Forward, a non-profit that provides resources and education towards developing a diverse, equitable, and inclusive venture ecosystem. She is also an advisory board member of Springboard Enterprises and the Women’s Health Innovation Coalition.
A bioengineer by training, Jennifer is passionate about the role that venture investing can bring to discovery in the fields of health care and life sciences. She is currently leading SVB Capital’s Life Science & Healthcare investment team and helping develop the bank’s first life science direct investment fund for institutional Limited Partners.
Jennifer has more than 20 years of experience in the venture and startup market segments, including leading and building several teams over the past 8 years at Silicon Valley Bank. Prior to that, she was a director on Pfizer's Venture Capital team, where she helped lead or co-lead investments into several life sciences companies, led fund-of-fund investment decisions, and independently managed Pfizer’s $250 million private equity portfolio. Jennifer has also served as a consultant on private equity deals across Europe while at Bain & Company and has held operational and research roles at Chiron, Genelabs, and Genencor.
Jennifer graduated magna cum laude with a BSE in Bioengineering and a Master's of Biotechnology from the University of Pennsylvania. She holds an MBA from the Wharton School, where she was named a Joseph Wharton Fellow. She also serves as an independent director at Alexandria Real Estate Equities, Inc.
Jennifer lives in the Bay Area with her husband and their twin children.